Page results
-
A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
A large trial at UCLH is looking to optimise chemotherapy for young people with nodular lymphocyte predominant Hodgkin lymphoma (NLPHL).
-
Self Care week raises awareness of how people can help to manage their health condition well. The UCH Macmillan Support and Information Service is available to support people manage well following a diagnosis of cancer or a blood condition. This article outlines the support available.
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Tuesday 31 January 2023.
-
We are looking for patient representatives to give us feedback on their experience, ensuring that the patient voice is heard and helping us to improve our service. If you are interested in this role or would like more information please email gemma.french1@nhs.net
-
Young cancer patients and staff couldn’t believe their eyes when David Beckham paid a visit to the University College Hospital Macmillan Cancer Centre earlier this year.
-
UCLH is to trial a set of interventions to improve hospital care for people who use opioids such as heroin.
File results
-
FOI/2023/0515 - Visitor policy in response to Covid-19
-
FOI/2023/0513 - Radiology equipment inventory
-
FOI/2023/0497 - List of all laboratories within Pathology
-
FOI/2023/0486 - Mastectomy reconstruction
-
FOI/2023/0484 - Babies diagnosed with Tongue Tie
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0305 - Trust held non-pharmaceutical consignment stock holding
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine